Calamos Advisors’s AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share AEON.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-83,333
| Closed | -$121K | – | 989 |
|
|
2024
Q1 | $121K | Hold |
83,333
| – | – | ﹤0.01% | 772 |
|
|
2023
Q4 | $7.28K | Hold |
83,333
| – | – | ﹤0.01% | 829 |
|
|
2023
Q3 | $12.5K | Hold |
83,333
| – | – | ﹤0.01% | 816 |
|
|
2023
Q2 | $7.5K | Hold |
83,333
| – | – | ﹤0.01% | 902 |
|
|
2023
Q1 | $5.46K | Hold |
83,333
| – | – | ﹤0.01% | 1068 |
|
|
2022
Q4 | $3.8K | Hold |
83,333
| – | – | ﹤0.01% | 1134 |
|
|
2022
Q3 | $6K | Buy |
+83,333
| New | +$6K | ﹤0.01% | 1167 |
|